King Faisal Specialist Hospital & Research Centre (KFSHRC) has achieved a remarkable success in stem cell science, securing a US patent.
According to the Saudi Press Agency (SPA), the medical team has secured the patent in recognition of an innovative technology for breast cancer treatment.
Crucially, the new technology transforms the regular breast cells into multipotent stem cells.
Consequently, doctors can use these stem cells to rebuild tissues damaged by chemotherapy or surgery.
Moreover, they play a pivotal role in the development of more effective treatments with fewer side effects.
Fortunately, these stem cells have proven the ability to regenerate mammary tissue in animal models. In other words, they present new possibilities for breast tissue reconstruction and advanced cancer therapies.
Developed by KFSHRC researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebe, the new innovation serves as a promising foundation for personalized breast cancer treatment.
Published in the Molecular and Cellular Biology journal, the technology offers the possibility of providing reconstruction options for patients during the post-surgery period.
It stands as a testament to KFSHRC’s dedication to advancing life-saving therapies that address the needs of cancer patients worldwide.
Furthermore, it boosts its position as prestigious medical hub and pioneer in advanced therapies, including localized CAR T-cell treatment for cancer.
Related Topics:
KFSHRC Ranked among World’s Best Smart Hospitals for 2025
IAU Neurology Conference Opens in Khobar, Marking Significant Global Collaboration
KFSHRC Performs Robotic Surgery to Identify Focal Seizure Areas, Implant Chips in the Brain
